Your trusted source for the latest news and insights on Markets, Economy, Companies, Money, and Personal Finance.
Popular

What is the Total Value of Hanes?

Key Points

  • Hanesbrands is a global apparel maker with iconic brands, including Champion, Hands, Maidenform, Playtex and Wonderbra, trying to implement a turnaround strategy.
  • The company lowered Q3 and full-year 2023 guidance for top and bottom lines.
  • The company announced a “strategic review” for selling its Champion athleisure business without assurances that it would get done as investors dumped more shares, indicating management lost its credibility.
  • 5 stocks we like better than Hanesbrands

Global apparel maker Hanesbrands Inc. NYSE: HBI shares have been in a cascading fall, shedding 37.7% year-to-date (YTD). The company owns many innerwear and athleisure brands, including Hanes, Champion, Playtex, L’eggs, Wonderbra, Bonds, Bali, Maidenform, Berlei, Just My Size, Alternative and Comfortwash. The company has been behind the curve at every turn. During the pandemic reopening, Hanesbrands overproduced apparel, growing its inventory when cotton prices were at historic highs of $160 per pound. The vertically integrated company owns 60% of the factories that produce its wares and operates more than 200 physical stores.

Mountain of Inventory

Like many retail and apparel makers like Under Armour Inc. NYSE: UAA, Hanesbrands overshot demand estimates, producing a mountain of inventory. Unfortunately, apparel demand fell with rising inflation, forcing the company to implement deep discounts and mark-offs to reduce its inventory, with sky-high freight costs wreaking havoc on margins for years. Activist investors like Barrington Capital Group have been trying to get management to turn the boat around. On September 20, 2023, Hanesbrands announced that it was considering selling off its Champion athleisure apparel business.

Barrington Capital Suggestions

Hanesbrands management has been meeting with activist investor Barrington Capital to review suggestions. Barrington suggests that Hanesbrands needs to generate cash, reduce debt and create sustainable shareholder value. They suggest the company reduce its SG&A expenses by $300 million annually and use the proceeds for debt reduction. Reduce inventories to less than 170 days outstanding. Accelerate gross margin recovery by consolidating facility and operations process improvements. Barrington sent and publicized a letter to the Board criticizing the poor execution under the current leadership, suggesting a new CEO and new directors are necessary.

Disappointment Grows

Hanesbrands reported its second-quarter 2023 earnings results on August 10, 2023. The company reported a loss of one cent, beating consensus analyst estimates for a loss of two cents by one cent. Revenues fell 4.7% YoY to $1.44 billion, missing $1.46 billion analyst estimates.

Lowering the Bar

Hanesbrands lowered its Q3 2023 EPS from seven cents to 13 cents versus 20 cents consensus analyst estimates. Q3 2023 revenues are expected between $1.52 to $1.57 billion, missing $1.69 billion analyst estimates. Full-year 2023 EPS is expected between 16 cents to 30 cents, down from previous estimates of 31 cents to 40 cents, versus 33 cents consensus analyst estimates. Full-year revenues are expected between $5.8 to $5.9 billion, down from $6.05 to $6.20 billion, versus $6.04 billion analyst estimates.

Champion Brand Sale?

On September 19, 2023, Hanesbrands announced it would evaluate “strategic options” for its Champion brand business. The Board will consider many options to enhance shareholder value, which could include a potential sale or other strategic transaction and continue operating it. Hanesbrands CEO Steve Bratspies commented, “As the Board pursues this review of strategic options with the support of our advisors, our team remains focused on executing across our operations, continuing to serve our customers and consumers globally and advancing our initiatives to drive revenue growth, margin improvement and greater cash flow.”

Management’s Credibility in Question

The press release also notes that there is no assurance that they will pursue any strategic alternative and has not set a timetable for completion of the evaluation. The company will use the Goldman Sachs Group Inc. NYSE: GS as advisors for the review. Incidentally, HBI stock fell from $4.50 to $4.19 in the proceeding days towards 52-week lows. This indicates that management has lost credibility with shareholders as they don’t believe the company will sell Champion.

Hanesbrands analyst ratings and price targets can be found on usafinancetrends. Hanesbrands peers and competitor stocks can be found with the usafinancetrends stock screener.

Weekly Bear Flags

The weekly candlestick chart has had three bear flag breakdowns since June 2022, causing shares to fall from $11.33 to a low of $3.85 in May 2023. Bear flags occur after a sharp sell-off followed by a bounce with parallel ascending trendlines. This sucks in buyers only to rug-pull them when the stock falls back under the lower ascending trendline. The breakdown through its recent lows frequently causes more panic and takes shares to new lows. The most recent bear flag triggered on the September 19, 2023, announcement of a strategic review of its Champion brand segment. The weekly market structure high (MSH) triggered the breakdown below $4.93, sending shares to $4.19 but not yet breaking its $3.85 low. The weekly relative strength index (RSI) oscillator returns to the 40-band.

Before you consider Hanesbrands, you’ll want to hear this.

Share this article
Shareable URL
Prev Post

Writers’ Strike Resolution Could Bring Shows Back to Airwaves in Days

Next Post

5 Undervalued Semiconductor Stocks to Invest In Before Q3 Earnings

Leave a Reply

Your email address will not be published. Required fields are marked *

Read next
Key Factors Markets received a actuality examine as the newest readings on inflation got here in hotter than…
Key Factors DraftKings achieved a powerful year-over-year income enhance, exceeding expectations and…
Key Factors The Charles Schwab Firm had a good quarter and is predicted to return to progress quickly. Margins…
Novavax NASDAQ: NVAX is a drug and vaccine producer within the healthcare sector identified for its efforts…